Literature DB >> 15320879

The receptor for interleukin-17E is induced by Th2 cytokines in antigen-presenting cells.

A Gratchev1, J Kzhyshkowska, K Duperrier, J Utikal, F W Velten, S Goerdt.   

Abstract

Interleukin-17E (IL-17E) (IL-25) is a recently identified cytokine capable to induce Th2-associated cytokine production (IL-5 and IL-13) and T helper 2 (Th2)-type pathologies in animal models. The IL-17E-responsive cell population in vivo was described to be a further uncharacterized non-T-, non-B-splenic accessory cell. Despite the identification of IL-17BR as the receptor for IL-17E, the cell population expressing IL-17BR has hitherto not been identified. Here, we show that human monocyte-derived Th2-skewed antigen-presenting cells (APC2) express membrane-bound and soluble forms of IL-17BR on the mRNA and protein level upon stimulation with IL-4, IL-10, IL-13 or transforming growth factor-betain vitro. These results indicate that IL-17BR-expressing APC2s may mediate the development of the IL-17E-mediated immunological reaction patterns observed in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15320879     DOI: 10.1111/j.0300-9475.2004.01443.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  16 in total

Review 1.  The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines.

Authors:  Hongwei Han; Florence Roan; Steven F Ziegler
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

Review 2.  Innate cells and T helper 2 cell immunity in airway inflammation.

Authors:  Nora A Barrett; K Frank Austen
Journal:  Immunity       Date:  2009-09-18       Impact factor: 31.745

Review 3.  Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites.

Authors:  Steven A Saenz; Betsy C Taylor; David Artis
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

4.  MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors.

Authors:  Jietang Mai; Anthony Virtue; Erin Maley; Tran Tran; Ying Yin; Shu Meng; Meghana Pansuria; Xiaohua Jiang; Hong Wang; Xiao-Feng Yang
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

5.  Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract.

Authors:  Alexander M Owyang; Colby Zaph; Emma H Wilson; Katherine J Guild; Terrill McClanahan; Hugh R P Miller; Daniel J Cua; Michael Goldschmidt; Christopher A Hunter; Robert A Kastelein; David Artis
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

6.  IL-25 regulates Th17 function in autoimmune inflammation.

Authors:  Melanie A Kleinschek; Alexander M Owyang; Barbara Joyce-Shaikh; Claire L Langrish; Yi Chen; Daniel M Gorman; Wendy M Blumenschein; Terrill McClanahan; Frank Brombacher; Stephen D Hurst; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

7.  Macrophages in immunopathology of atherosclerosis: a target for diagnostics and therapy.

Authors:  Alexander N Orekhov; Igor A Sobenin; Mikhail A Gavrilin; Alexei Gratchev; Svetlana Y Kotyashova; Nikita G Nikiforov; Julia Kzhyshkowska
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

8.  Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients.

Authors:  Christian J Lechner; Beate Grüner; Xiangsheng Huang; Wolfgang H Hoffmann; Peter Kern; Peter T Soboslay
Journal:  Clin Dev Immunol       Date:  2012-08-30

9.  Expression of Osteoarthritis Marker YKL-39 is Stimulated by Transforming Growth Factor Beta (TGF-beta) and IL-4 in Differentiating Macrophages.

Authors:  Alexei Gratchev; Christina Schmuttermaier; Srinivas Mamidi; Liming Gooi; Sergij Goerdt; Julia Kzhyshkowska
Journal:  Biomark Insights       Date:  2008-02-14

10.  IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity.

Authors:  Mario M Zaiss; Kendle M Maslowski; Ilaria Mosconi; Nadine Guenat; Benjamin J Marsland; Nicola L Harris
Journal:  PLoS Pathog       Date:  2013-08-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.